Skip to content
10-K

Annual Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-13-000012

← back to feed
Filed
Aug 13, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Jul 5, 2013 111.55M sh
Operating Cash Flow FY 2013 · Jun 30, 2013 −$2.08M
Operating Cash Flow FY 2013 · Jun 30, 2011 −$127.16K
Net Income FY 2013 · Jun 30, 2013 −$2.06M
Operating Income FY 2013 · Jun 30, 2013 −$2.35M
Cash And Equivalents FY 2013 · Jun 30, 2012 $2.57K
Total Liabilities FY 2013 · Jun 30, 2012 $2.09M
Current Assets FY 2013 · Jun 30, 2012 $8.84K